France's IMPLANET FY25 revenue up 33% on higher exports

Implanet SA

24/02/2026 16:59

Overview

France-based medical technology firm's 2025 revenue up 33% to €12.5 mln

Net income from continuing operations improved by 16% yr/yr

Company plans to expand JAZZ distribution in China

Outlook

IMPLANET plans to strengthen U.S. presence by recruiting experienced sales force

Company aims to expand JAZZ distribution in China, the largest spine market

Result Drivers

COMMERCIAL EXPANSION - Revenue growth driven by commercial expansion in the U.S. and rollout of new products like Jazz Spinal System and Olea ultrasonic scalpel

SPINE IMPLANTS GROWTH - Spine Implants business revenue increased by 22% yr/yr, contributing significantly to overall revenue growth

INTERNATIONAL SALES - Export sales increased by 55%, driven by JAZZ deliveries in China and JSS solution rollout

Company press release: ID:nBw7tcRMPa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Net Income
-EUR 4.38 mln
FY Operating Income
-EUR 4.22 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)